𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9003 Response and progression-free survival in 1006 patients with known EGFR mutation status in phase III randomized trials of gefitinib in individuals with non-small cell lung cancer

✍ Scribed by Kris, M.; Mok, T.; Kim, E.; Douillard, J.Y.; Fukuoka, M.; Thatcher, N.


Book ID
123093621
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
67 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES